[Case of posterior reversible encephalopathy syndrome caused by Fisher syndrome].

Abstract

This report presents a case of a 71-year-old woman with Fisher syndrome who had posterior reversible encephalopathy syndrome (PRES) before the initiation of intravenous immunoglobulin (IVIg) treatment. She had symptoms of common cold 2 weeks before the onset of PRES. On the day of the onset, she began to stagger while walking. On day 2, she developed hypertension, vision impairment, and limb weakness and was admitted to the hospital. On day 3, she was provided steroid pulse therapy. On day 4, she developed convulsions and right imperfection single paralysis and was transferred to the our hospital. During the transfer, the patient was conscious. Her blood pressure was high at 198/107 mmHg. She had mild weakness in her limbs and face, light perception in both eyes, dilation of both pupils, total external ophthalmoplegia, no tendon reflexes, and limb and trunk ataxia. We diagnosed PRES because of the high signal intensities observed on T2-weighted MRI on both sides of the parietal and occipital lobes. We also diagnosed Fisher syndrome because of a positive anti-GQ1b immunoglobulin G antibody test and albuminocytologic dissociation in the cerebrospinal fluid. PRES showed prompt improvement with antihypertensive therapy, whereas Fisher syndrome slowly improved over a course of 2 months. This case is the first report of PRES without IVIg suggesting that Fisher syndrome induces hypertension and causes PRES.

• Authors: Katsunori Yokoi, Tetsuo Ando, Osamu Kawakami
• Journal: Rinsho shinkeigaku = Clinical neurology (Rinsho Shinkeigaku) Vol. 58 Issue 1 Pg. 45-48 (Jan 26 2018) ISSN: 1882-0654 [Electronic] Japan
• PMID: 29269696 (Publication Type: Case Reports, Journal Article)

Chemical References

• Antihypertensive Agents
• Biomarkers
• Cerebrospinal Fluid Proteins
• Gangliosides
• Immunoglobulin G
• Immunoglobulins, Intravenous
• GQ1b ganglioside
• Valsartan
• Diltiazem

Topics

• Aged
• Antihypertensive Agents (administration & dosage)
• Biomarkers (blood, cerebrospinal fluid)
• Cerebrospinal Fluid Proteins (cerebrospinal fluid)
• Diltiazem (administration & dosage)
• Female
• Gangliosides (immunology)
• Humans
• Immunoglobulin G (blood)
• Immunoglobulins, Intravenous
• Magnetic Resonance Imaging
• Miller Fisher Syndrome (complications, diagnosis)
• Neuroimaging
• Posterior Leukoencephalopathy Syndrome (diagnostic imaging, drug therapy, etiology)
• Treatment Outcome
• Valsartan (administration & dosage)